Spyryx Biosciences Inc

Spyryx Biosciences, Inc. develops biopharmaceutical therapies for obstructive lung diseases. The Company conducts clinical trials for inhaled peptide treatments and researches novel approaches to restore epithelial hydration. Spyryx Biosciences Inc serves patients with Cystic Fibrosis and COPD in the United Kingdom, United States, and Canada.